2025 annual financial data
AgomAb Therapeutics 2025 Financial results
Direct answer
Revenue was 0 EUR.
Operating income was -59,275,000 EUR and net income was -60,078,438 EUR.
Operating cash flow was Not available.
Get free AgomAb Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 EUR
- Operating income
- -59,275,000 EUR
- Net income
- -60,078,438 EUR
- Operating cash flow
- Not available
Explore related company data
View all 2025 financial metricsView RevenueView Operating incomeView Net incomeView Operating cash flowView Revenue growthView Operating income growthView Net income growthView Operating cash flow growthView Operating marginView Net marginView Operating cash flow marginView all AgomAb Therapeutics financial years